Stock Situation Room

[NYC Trader]

NVLX Since January, the new management at Nuvilex has begun substantial efforts to add to its success by expanding into the biotechnology arena. As a result, a new acquisition of a pancreatic cancer treatment technology will initiate our growth and expansion into this area. The present status of this includes completed initial clinical trials in Europe with multiple directions for forward movement which are presently in the planning and initiation stages. Your new management, through their ongoing activities, believes will create a paradigm shift for Nuvilex into becoming a true Biotechnology and Natural Products leader. These actions are well underway and should provide excellent opportunities going forward. Dr. Robert Ryan stated, “Many more dramatic and exciting events are still to enter into our story, yet, they will be in keeping and allow us to stay true to our philosophy and motto…”
"Good for You, Good for the Environment."